Amanote Research
Register
Sign In
Cn3 - Value of Adjuvant Oncology Therapies: Methodological Challenges of Modelling Cost-Effectiveness of an Adjuvant Treatment in an Era of High-Cost Oncology Treatments
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.020
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
V. Kovacs
Z. Kiss
E. Tichy
A. Benedict
Publisher
Elsevier BV
Related search
Prm96 - Cost-Effectiveness of Precision Oncology Decisions: Challenges in Methodology
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Co-Administered Branded Therapies in Oncology: Pricing Insights From an Early Economic Model
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost to the NHS of Roche Oncology Treatments
Journal of the Royal Society of Medicine
Medicine
PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Utility Analysis of Adjuvant Therapies for Breast Cancer in Iran
International Journal of Technology Assessment in Health Care
Health Policy
Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies
Oncologist
Cancer Research
Medicine
Oncology
Use of Model Averaging Techniques in Cost-Effectiveness Analysis in Oncology
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Regarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”
Oncologist
Cancer Research
Medicine
Oncology
The Expanding Value Footprint of Oncology Treatments
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
